NCT01326715View on ClinicalTrials.gov

Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 17, 2013

Primary Completion Date

September 18, 2019

Study Completion Date

September 13, 2022

Conditions
Multiple Sclerosis
Interventions
DRUG

Mangafodipir (Teslascan)

gadolinium enhancement on contrast enhanced brain MRI.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT01326715 - Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis | Biotech Hunter | Biotech Hunter